Smaller firms should heed scientific advice to improve chances of success, says EMEA
This article was originally published in SRA
Since the European Medicines Agency opened its office for micro-, small- and medium-sized enterprises three years ago, 38 such companies have submitted marketing authorisation applications for new products, of which 33 were for human-use drugs and five for veterinary medicines, according to the office’s latest report1.
You may also be interested in...
Hungary is going its own way when it comes to coronavirus vaccines, but its decision to allow the emergency use of the Oxford University/AstraZeneca vaccine may be only a symbolic expression of the government’s growing impatience with the EU.
Valneva is scaling up manufacture of its coronavirus vaccine alongside the clinical development program, with a view to meeting its commitment to provide millions of doses for use in the UK and the EU.
The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.